Prediction of gestational diabetes based on nationwide electronic health records
- PMID: 31932807
- DOI: 10.1038/s41591-019-0724-8
Prediction of gestational diabetes based on nationwide electronic health records
Abstract
Gestational diabetes mellitus (GDM) poses increased risk of short- and long-term complications for mother and offspring1-4. GDM is typically diagnosed at 24-28 weeks of gestation, but earlier detection is desirable as this may prevent or considerably reduce the risk of adverse pregnancy outcomes5,6. Here we used a machine-learning approach to predict GDM on retrospective data of 588,622 pregnancies in Israel for which comprehensive electronic health records were available. Our models predict GDM with high accuracy even at pregnancy initiation (area under the receiver operating curve (auROC) = 0.85), substantially outperforming a baseline risk score (auROC = 0.68). We validated our results on both a future validation set and a geographical validation set from the most populated city in Israel, Jerusalem, thereby emulating real-world performance. Interrogating our model, we uncovered previously unreported risk factors, including results of previous pregnancy glucose challenge tests. Finally, we devised a simpler model based on just nine questions that a patient could answer, with only a modest reduction in accuracy (auROC = 0.80). Overall, our models may allow early-stage intervention in high-risk women, as well as a cost-effective screening approach that could avoid the need for glucose tolerance tests by identifying low-risk women. Future prospective studies and studies on additional populations are needed to assess the real-world clinical utility of the model.
Comment in
-
Electronic health records to predict GDM.Nat Rev Endocrinol. 2020 Mar;16(3):130. doi: 10.1038/s41574-020-0326-z. Nat Rev Endocrinol. 2020. PMID: 31996805 No abstract available.
-
Electronic Health Records to Predict Gestational Diabetes Risk.Trends Pharmacol Sci. 2020 May;41(5):301-304. doi: 10.1016/j.tips.2020.03.003. Epub 2020 Apr 1. Trends Pharmacol Sci. 2020. PMID: 32247548
References
-
- Lowe, L. P. et al. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations of maternal A1C and glucose with pregnancy outcomes. Diabetes Care 35, 574–580 (2012). - DOI
-
- Lowe, W. L. et al. Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity. JAMA 320, 1005–1016 (2018). - DOI
-
- Scholtens, D. M. et al. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): maternal glycemia and childhood glucose metabolism. Diabetes Care 42, 381–392 (2019). - DOI
-
- Zhao, P. et al. Maternal gestational diabetes and childhood obesity at age 9–11: results of a multinational study. Diabetologia 59, 2339–2348 (2016). - DOI
-
- Koivusalo, S. B. et al. Gestational diabetes mellitus can be prevented by lifestyle intervention: the Finnish gestational diabetes prevention study (RADIEL): a randomized controlled trial. Diabetes Care 39, 24–30 (2016). - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
